MIR29C: A Potential Drug Target and Biomarker (G407026)
MIR29C: A Potential Drug Target and Biomarker
MIR29C, also known as MIRN29C, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research on its potential implications for human health.
MIR29C is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs are made from a pool of non-coding RNAs and are responsible for regulating gene expression by binding to specific target mRNAs. This process is known as post-transcriptional regulation and is a critical mechanism that helps cells maintain a precise balance of gene expression.
One of the defining features of MIR29C is its unique structure. It is a small molecule that consists of only 19 amino acid residues and has a calculated molecular weight of 13.9 kDa. Despite its small size, MIR29C has a highly conserved core structure that is typical of miRNAs. The most conserved region of MIR29C is the first exon, which has a conserved GCAc sequence and is responsible for starting the translation process.
MIR29C has been shown to play a crucial role in various biological processes, including cell growth, apoptosis, and inflammation. One of the most significant findings related to MIR29C is its involvement in cancer progression. Several studies have shown that MIR29C is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This overexpression is associated with cancer cell survival and the development of invasive and metastatic phenotypes.
In addition to its role in cancer, MIR29C has also been shown to be involved in other biological processes. For example, it has been shown to play a role in cell apoptosis, which is the process by which cells self-destruct. shown to interact with the protein Bax, which is involved in cell apoptosis. This interaction suggests that MIR29C may be a potential drug target for apoptosis-related diseases.
Another potential function of MIR29C is its role in inflammation. MIR29C has been shown to be involved in the regulation of immune and inflammatory responses. This involvement has led to the hypothesis that MIR29C may be a potential drug target for diseases that are characterized by chronic inflammation , such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD).
In conclusion, MIR29C is a unique and highly conserved non-coding RNA molecule that has been shown to play a crucial role in various biological processes, including cancer, apoptosis, and inflammation. Its potential as a drug target and biomarker make it an attractive target for further research and development. As research continues to uncover the functions of MIR29C and its potential implications for human health, it is clear that MIR29C is an important molecule to study and may be a valuable tool for the development of new treatments for a variety of diseases.
Protein Name: MicroRNA 29c
The "MIR29C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR29C comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176
